Address

Other Office
21 Waterway Avenue,
Suite 225
The Woodlands, TX 77380
United States

Open map


Recent investment activity

KANDO id: 30232

Corporate information

Registration country

Funds managed

Fund Type Vintage Currency Committed capital
Essex Woodlands Health Ventures Fund VIII LP 2008
Essex Woodlands Health Ventures Fund V LP 2000 USD 245,000,000

Funding rounds

Top investment portfolio themes


Investment activity status
Active investor

Selected investments

Displaying 1 - 20 of 104
Profile Country Date Funding
Abiomed Produces the Impella product line, the world's smallest, minimally invasive, high performance micro blood pump with integrated motors and sensors. N/A
BENU Inc N/A
BioForm Medical Inc Is a medical aesthetics company dedicated to bringing doctors and their patients safe and effective products. N/A
Biotoscana A pharmaceutical multinational company with subsidiaries in Latin America. N/A
Bioventus LLC Leading orthopedic biologics company N/A
Care Guide N/A
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series C
Cell Biosciences Inc N/A
ceptiontx Emerging biopharmaceutical company which develops novel products to address unmet medical needs N/A
China Cord Blood Corp Leads in the Chinese cord blood collection industry N/A
Clear Vascular Inc Develops innovative cardiovascular products N/A
Confluent Surgical Inc A medical device company leading in the field of surgical sealants and adhesion barriers for use in neurosurgery, gynecologic and general surgery. Series C
Confluent Surgical Inc A medical device company leading in the field of surgical sealants and adhesion barriers for use in neurosurgery, gynecologic and general surgery. Series D
Cord Blood Registry Collects, processes and cryogenically freezes storage of stem cells N/A
Corium International Inc N/A
Curis Inc Develops innovative therapeutics targeting cancer network disruption N/A
Dow Pharmaceutical Sciences LLC N/A
Echo Therapeutics Develops needle-free, wireless, transdermal continuous glucose monitoring system. N/A
Elusys Therapeutics Inc Develops antibody-based therapies to treat infectious diseases. N/A
Endologix Inc Develops and manufactures minimally invasive treatments for vascular diseases. N/A

Financials